{"doi":"10.2310/7750.2013.13116","title":"Mosaic Generalized Neurofibromatosis 1: Report of Two Cases","abstract":"<jats:sec>\n                    <jats:title>Background:</jats:title>\n                    <jats:p>We report two cases of mosaic generalized neurofibromatosis 1 (NF1) and review the history of the classification of segmental neurofibromatosis (SNF; Ricardi type NF-V). Somatic mutations giving rise to limited disease, such as segmental neurofibromatosis are manifestations of mosaicism. If the mutation occurs before tissue differentiation, the clinical phenotype will be generalized disease. Mutations that occur later in development give rise to disease that is confined to a single region.</jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:</jats:title>\n                    <jats:p>Segmental neurofibromatosis is caused by a somatic mutation of neurofibromatosis type 1, and should not be regarded as a distinct entity from neurofibromatosis 1. Cases previously referred to as unilateral or bilateral segmental neurofibromatosis are now best referred to as mosaic generalized or mosaic localized neurofibromatosis 1.</jats:p>\n                  </jats:sec>","journal":"Journal of Cutaneous Medicine and Surgery","year":2014,"id":652057,"datarank":0.32958368660043297,"base_score":2.1972245773362196,"endowment":2.1972245773362196,"self_citation_contribution":0.32958368660043297,"citation_network_contribution":0.0,"self_endowment_contribution":0.32958368660043297,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":8,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1700838,"name":"Allan Behm","orcid":null,"position":1,"is_corresponding":false},{"id":1700839,"name":"Richard M. Haber","orcid":null,"position":2,"is_corresponding":false},{"id":1700837,"name":"Jori Hardin","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Mosaic Generalized Neurofibromatosis 1: Report of Two Cases","abstract":"<jats:sec>\n                    <jats:title>Background:</jats:title>\n                    <jats:p>We report two cases of mosaic generalized neurofibromatosis 1 (NF1) and review the history of the classification of segmental neurofibromatosis (SNF; Ricardi type NF-V). Somatic mutations giving rise to limited disease, such as segmental neurofibromatosis are manifestations of mosaicism. If the mutation occurs before tissue differentiation, the clinical phenotype will be generalized disease. Mutations that occur later in development give rise to disease that is confined to a single region.</jats:p>\n                  </jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:</jats:title>\n                    <jats:p>Segmental neurofibromatosis is caused by a somatic mutation of neurofibromatosis type 1, and should not be regarded as a distinct entity from neurofibromatosis 1. Cases previously referred to as unilateral or bilateral segmental neurofibromatosis are now best referred to as mosaic generalized or mosaic localized neurofibromatosis 1.</jats:p>\n                  </jats:sec>","is_dataset_classified":null,"base_score":2.1972245773362196,"endowment":2.1972245773362196,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25008444","pmcid":null,"openalex_id":"https://openalex.org/W2101962451","authors":[],"funders":[],"total_grants":0,"fwci":0.8472,"citation_percentile":0.75040897,"influential_citations":0,"citation_trend":[{"year":2016,"count":3},{"year":2017,"count":1},{"year":2019,"count":1},{"year":2020,"count":2},{"year":2021,"count":1}],"oa_status":"closed","license":"https://journals.sagepub.com/page/policies/text-and-data-mining-license","oa_locations":[{"url":"https://journals.sagepub.com/doi/pdf/10.2310/7750.2013.13116","host_type":"publisher"},{"url":"https://journals.sagepub.com/doi/full-xml/10.2310/7750.2013.13116","host_type":"publisher"},{"url":"https://doi.org/10.2310/7750.2013.13116","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25008444","host_type":"repository"}],"fields_of_study":["Neurofibromatosis and Schwannoma Cases","Soft tissue tumors and treatment","Neuroblastoma Research and Treatments"],"mesh_terms":["Female","Humans","Male","Middle Aged","Mosaicism","Neurofibromatosis 1","Neurofibromatoses"],"keywords":["Neurofibromatosis","Medicine","Neurofibromatoses","Neurofibromin 1","Disease","Mutation","Pathology","Dermatology","Genetics","Biology","Gene"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-10T11:44:59.154998Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}